(2021) Preventive cancer vaccination with P5 HER-2/neo-derived peptide-pulsed peripheral blood mononuclear cells in a mouse model of breast cancer. Biochemistry and Cell Biology. pp. 435-446. ISSN 0829-8211

(2021) Protective immune response against P32 oncogenic peptide-pulsed PBMCs in mouse models of breast cancer. International Immunopharmacology.

(2020) Development and Evaluation of Novel Aptamers Specific for Human PD1 Using Hybrid Systematic Evolution of Ligands by Exponential Enrichment Approach. Immunological Investigations. pp. 535-554.

(2019) Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection. Viral Immunology. pp. 89-94. ISSN 1557-8976 (Electronic) 0882-8245 (Linking)

(2019) Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells <i>in vitro</i> and <i>in vivo</i>. Drug development and industrial pharmacy. pp. 603-610. ISSN 0363-9045

(2016) Protective role of R381Q (rs11209026) polymorphism in <i>IL-23R</i> gene in immune-mediated diseases: A comprehensive review. Journal of Immunotoxicology. pp. 286-300. ISSN 1547-691X